Range
1.04 - 1.05
Vol / Avg.
7.1K/5.5K
Div / Yield
-
52 Wk
0.86 - 1.32
Mkt Cap
63.9M
Payout Ratio
-
Open
1.05
P/E
-
EPS
-0.03
Shares
61.5M
Outstanding
-
Total Float
-
There is no Press for this Ticker
Arch Biopartners Inc is a clinical stage company developing technologies with the potential to make medical or commercial impacts. The company is developing a drug platform Metablok to produce drug candidates to inhibit organ inflammation caused via the DPEP-1 pathway. Its under development portfolio is AB569, a potential new treatment for antibiotic resistant bacterial infections in the lungs or wounds; and, Borg peptide coatings that increase corrosion resistance and decrease bacterial biofilm on various medical grade metals and plastics.

Related Companies

TickerCompanyChg %Mkt Cap
ACHFFArch Biopartners4.48%63.9M

Arch Biopartners Company Questions & Answers

Q

How do I buy Arch Biopartners (ACHFF) stock?

A

You can purchase shares of Arch Biopartners (OTC: ACHFF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Arch Biopartners's (ACHFF) main competitors?

A

There are no as such competitors for Arch Biopartners.

Q

What is the target price for Arch Biopartners?

A

There is no analysis for Arch Biopartners

Q

How much is Arch Biopartners (ACHFF) stock ?

A

The stock price for Arch Biopartners (OTC: ACHFF) is $1.04 last updated Fri May 14 2021 18:12:34 GMT+0000 (Coordinated Universal Time).

Q

When is the next Arch Biopartners (ACHFF) dividend?

A

There are no upcoming dividends for Arch Biopartners.

Q

When is Arch Biopartners (OTC:ACHFF) reporting earnings?

A

There are no earnings for Arch Biopartners

Q

When is the upcoming split for ACHFF?

A

There is no upcoming split for Arch Biopartners.